These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24811064)

  • 41. First-trimester metabolomic detection of late-onset preeclampsia.
    Bahado-Singh RO; Akolekar R; Mandal R; Dong E; Xia J; Kruger M; Wishart DS; Nicolaides K
    Am J Obstet Gynecol; 2013 Jan; 208(1):58.e1-7. PubMed ID: 23159745
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?
    Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
    Arch Gynecol Obstet; 2013 May; 287(5):865-73. PubMed ID: 23224699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic Value of Cardiovascular Disease Risk Factors Measured in the First-Trimester on the Severity of Preeclampsia.
    Cheng PJ; Huang SY; Su SY; Hsiao CH; Peng HH; Duan T
    Medicine (Baltimore); 2016 Feb; 95(5):e2653. PubMed ID: 26844488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating microRNA expression as predictor of preeclampsia and its severity.
    Jairajpuri DS; Malalla ZH; Mahmood N; Almawi WY
    Gene; 2017 Sep; 627():543-548. PubMed ID: 28694210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Importance of Timing First-Trimester Placental Growth Factor and Use of Serial First-Trimester Placental Growth Factor Measurements in Screening for Preeclampsia.
    Mosimann B; Amylidi-Mohr S; Höland K; Surbek D; Risch L; Raio L
    Fetal Diagn Ther; 2017; 42(2):111-116. PubMed ID: 28199996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantification of circulating miR-517c-3p and miR-210-3p levels in preeclampsia.
    Nejad RMA; Saeidi K; Gharbi S; Salari Z; Saleh-Gohari N
    Pregnancy Hypertens; 2019 Apr; 16():75-78. PubMed ID: 31056162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distinct First Trimester Cytokine Profiles for Gestational Hypertension and Preeclampsia.
    Tangerås LH; Austdal M; Skråstad RB; Salvesen KÅ; Austgulen R; Bathen TF; Iversen AC
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2478-85. PubMed ID: 26404486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. First-trimester maternal cell microRNA is a superior pregnancy marker to immunological testing for predicting adverse pregnancy outcome.
    Winger EE; Reed JL; Ji X
    J Reprod Immunol; 2015 Aug; 110():22-35. PubMed ID: 25965838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential role of circulating microRNAs as early markers of preeclampsia.
    Ura B; Feriotto G; Monasta L; Bilel S; Zweyer M; Celeghini C
    Taiwan J Obstet Gynecol; 2014 Jun; 53(2):232-4. PubMed ID: 25017274
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MiR-942 decreased before 20 weeks gestation in women with preeclampsia and was associated with the pathophysiology of preeclampsia in vitro.
    Zhang Y; Huang G; Zhang Y; Yang H; Long Y; Liang Q; Zheng Z
    Clin Exp Hypertens; 2017; 39(2):108-113. PubMed ID: 28287888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maternal serum adiponectin at 11-13 weeks of gestation in preeclampsia.
    Nanda S; Yu CK; Giurcaneanu L; Akolekar R; Nicolaides KH
    Fetal Diagn Ther; 2011; 29(3):208-15. PubMed ID: 21266793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-throughput deep screening and identification of four peripheral leucocyte microRNAs as novel potential combination biomarkers for preeclampsia.
    Wang Y; Yang X; Yang Y; Wang W; Zhao M; Liu H; Li D; Hao M
    J Perinatol; 2016 Apr; 36(4):263-7. PubMed ID: 26675000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low maternal serum pregnancy-associated plasma protein-A as a risk factor of preeclampsia.
    Luewan S; Teja-Intr M; Sirichotiyakul S; Tongsong T
    Singapore Med J; 2018 Jan; 59(1):55-59. PubMed ID: 28451695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Second-trimester maternal serum markers in the prediction of preeclampsia.
    Luo Q; Han X
    J Perinat Med; 2017 Oct; 45(7):809-816. PubMed ID: 27935854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early-onset severe preeclampsia by first trimester pregnancy-associated plasma protein A and total human chorionic gonadotropin.
    Jelliffe-Pawlowski LL; Baer RJ; Currier RJ; Lyell DJ; Blumenfeld YJ; El-Sayed YY; Shaw GM; Druzin ML
    Am J Perinatol; 2015 Jun; 32(7):703-12. PubMed ID: 25519199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. First trimester serum biomarker discovery study for early onset, preterm onset and preeclampsia at term.
    Beernink RHJ; Zwertbroek EF; Schuitemaker JHN; Cremers TIFH; Scherjon SA
    Placenta; 2022 Oct; 128():39-48. PubMed ID: 36058050
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of next-generation sequencing technology to profile the circulating microRNAs in the serum of preeclampsia versus normal pregnant women.
    Yang Q; Lu J; Wang S; Li H; Ge Q; Lu Z
    Clin Chim Acta; 2011 Nov; 412(23-24):2167-73. PubMed ID: 21840305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-Coding RNAs and Prediction of Preeclampsia in the First Trimester of Pregnancy.
    Ogoyama M; Takahashi H; Suzuki H; Ohkuchi A; Fujiwara H; Takizawa T
    Cells; 2022 Aug; 11(15):. PubMed ID: 35954272
    [TBL] [Abstract][Full Text] [Related]  

  • 59. First- and second-trimester maternal serum markers of pre-eclampsia in twin pregnancy.
    Svirsky R; Levinsohn-Tavor O; Feldman N; Klog E; Cuckle H; Maymon R
    Ultrasound Obstet Gynecol; 2016 May; 47(5):560-4. PubMed ID: 25865365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery and Verification of Extracellular miRNA Biomarkers for Non-invasive Prediction of Pre-eclampsia in Asymptomatic Women.
    Srinivasan S; Treacy R; Herrero T; Olsen R; Leonardo TR; Zhang X; DeHoff P; To C; Poling LG; Fernando A; Leon-Garcia S; Knepper K; Tran V; Meads M; Tasarz J; Vuppala A; Park S; Laurent CD; Bui T; Cheah PS; Overcash RT; Ramos GA; Roeder H; Ghiran I; Parast M; ; Breakefield XO; Lueth AJ; Rust SR; Dufford MT; Fox AC; Hickok DE; Burchard J; Boniface JJ; Laurent LC
    Cell Rep Med; 2020 May; 1(2):. PubMed ID: 32864636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.